Opens in a new tab

Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG

Published Scientific Evidence

Category: (Pulmonary Hypertension)

Anumana’s ECG-AI® technology is supported by one of the most extensive evidence bases in cardiovascular AI. This library provides direct access to our peer-reviewed validation studies and broader body of clinical research.

October
31
2020
{post_date: F d, Y}
American Thoracic Society (ATS) 2021 International Conference

An Automated Screening Algorithm Using Electrocardiograms for Pulmonary Hypertension

Pulmonary hypertension (PH) is a life-threatening disease that is typically detected after significant pulmonary vascular remodeling has occurred. Longer diagnostic delays are associated with higher mortality and there is a…
October
31
2020
{post_date: F d, Y}
American Journal of Respiratory and Critical Care Medicine / American Thoracic Society (ATS) 2021 International Conference

An Automated Screening Algorithm Using Electrocardiograms for Pulmonary Hypertension

Pulmonary hypertension (PH) is a life-threatening disease that is typically detected after significantpulmonary vascular remodeling has occurred. Longer diagnostic delays are associated with higher mortality andthere is a need for…